Cargando…
Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology
Ketamine is a non-competitive antagonist of NMDA (N-methyl-D-aspartate) receptor, which has been in clinical practice for over a half century. Despite recent data suggesting its harmful side effects, such as neuronal loss, synapse dysfunction or disturbed neural network formation, the drug is still...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665128/ https://www.ncbi.nlm.nih.gov/pubmed/33182497 http://dx.doi.org/10.3390/ijms21218410 |